Publications
Product
Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegoprazan orally disintegrating tablet (ODT) administered via nasogastric tube or oral dosing (cPMTb)
Transl Clin Pharmacol. 32(2):98-106 / 2024.06 [LINK]
Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects (cPMTb)
Transl Clin Pharmacol. 31(2):114-123 / 2023.06 [LINK]
Associations between HLA-A, -B, and -C alleles and iodinated contrast media-induced hypersensitivity in Koreans (cPMTb)
Transl Clin Pharmacol. 29(2):107-116 / 2021.06 [LINK]
Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy (cPMTb)
Transl Clin Pharmacol. 28(1):34-42 / 2020.03 [LINK]
Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects (cPMTb)
Drug Des Devel Ther. 3:13:991-997 / 2019.04 [LINK]
Pharmacodynamic effects of voglibose administered alone, administered with metformin and administered with metformin in a fixed-dose combination in healthy Korean subjects (cPMTb)
Int J Clin Pharmacol Ther. 56(11):544-550 / 2018.11 [LINK]
Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects (cPMTb)
Drug Des Devel Ther. 8:12:1157-1164 / 2018.05 [LINK]
Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals. (BMRC)
Pharmacogenet Genomics. 23(3):175-9 / 2013.03 [LINK]
2013-International
The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype. (BMRC)
Pharmacogenet Genomics. 21(12):820-8 / 2011.12 [LINK]
2011-International 
1 
